Data gathered: November 27
AI Stock Analysis - Longeveron (LGVN)
Analysis generated August 12, 2024. Powered by Chat GPT.
Longeveron Inc. is a biotechnology company that focuses on the development and commercialization of cell-based therapies for aging-related chronic diseases and other life-threatening conditions. The company's flagship product, Lomecel-B, is designed to address a variety of conditions, including Alzheimer's disease, hypoplastic left heart syndrome (HLHS), aging frailty, and other indications. The company's innovative approach taps into regenerative medicine, making it a unique player in the biotechnology sector.
Stock Alerts - Longeveron (LGVN)
 |
Longeveron | November 25 Price is up by 5.8% in the last 24h. |
|
Longeveron | November 19 Price is down by -5.7% in the last 24h. |
|
Longeveron | November 18 Price is down by -5.1% in the last 24h. |
|
Longeveron | November 15 Price is down by -7.2% in the last 24h. |
Alternative Data for Longeveron
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 90 | Sign up | Sign up | Sign up |
| Webpage traffic | 210,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 462 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 7 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 13,565 | Sign up | Sign up | Sign up |
| Twitter Followers | 332 | Sign up | Sign up | Sign up |
| Twitter Mentions | 78 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 26 | Sign up | Sign up | Sign up |
About Longeveron
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan.
| Price | $2.06 |
| Target Price | Sign up |
| Volume | 142,780 |
| Market Cap | $29M |
| Year Range | $0.82 - $4.55 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
HC Wainwright Reiterates Buy Rating for Longeveron (NASDAQ:LGVN)November 26 - ETF Daily News |
 |
We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn RateNovember 14 - Yahoo |
 |
LGVN Highlights Potential Groundbreaking TreatmentsNovember 12 - Yahoo |
 |
Longeveron, Inc. (LGVN) Q3 2024 Earnings Call TranscriptNovember 12 - SeekingAlpha |
 |
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12 - Yahoo |
 |
Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)November 10 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 770,000 | 91,000 | 680,000 | -4.4M | -4.4M | -0.340 |
| Q2 '24 | 470,000 | 120,000 | 340,000 | -3.4M | -3.3M | -1.830 |
| Q1 '24 | 550,000 | 220,000 | 330,000 | -4.1M | -3.8M | -1.610 |
| Q4 '23 | 63,000 | 65,000 | -2,000 | -6M | -4.7M | -0.250 |
| Q3 '23 | 150,000 | 96,000 | 54,000 | -5.1M | -5.1M | -0.280 |
Insider Transactions View All
| Soffer Rock filed to buy 31,915 shares at $0.1. April 12 '24 |
| Hashad Mohamed Wa'el Ahmed filed to buy 10,638 shares at $0.1. April 12 '24 |
| Hare Joshua filed to buy 42,553 shares at $0.1. April 12 '24 |
| Soffer Rock filed to buy 106,383 shares at $0.1. April 12 '24 |
| Hare Joshua filed to buy 106,383 shares at $0.1. April 12 '24 |
Similar companies
Read more about Longeveron (LGVN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Longeveron?
The Market Cap of Longeveron is $29M.
What is the current stock price of Longeveron?
Currently, the price of one share of Longeveron stock is $2.06.
How can I analyze the LGVN stock price chart for investment decisions?
The LGVN stock price chart above provides a comprehensive visual representation of Longeveron's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Longeveron shares. Our platform offers an up-to-date LGVN stock price chart, along with technical data analysis and alternative data insights.
Does LGVN offer dividends to its shareholders?
As of our latest update, Longeveron (LGVN) does not offer dividends to its shareholders. Investors interested in Longeveron should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Longeveron?
Some of the similar stocks of Longeveron are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.